# 



## 

## 

|Report ofthe Trustees|1-15|
|---|---|
|Auditors'<br>Report|16-18|
|Statement ofFinancial Activities|19|
|Balance Sheet|20|
|Statement ofCash Flow|21|
|Notes to the Financial Statements|22-30|





## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 



## 

## 

## 



## 

## 



## 



## 

## 



## 

## 



## 

## 



## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



|||~14<br>IOao|~14<br>IOao|W||Pl <br>O<br>Ch|O|IV<br>Ch|ID|O<br>LA|||||h'ID<br>Ar||CI<br>CI|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||P\|LA||||||||Ch|||
|||||||CO||QO||'lD||||||||||
|||N<br>'CC||W||CO<br>PI<br>Af||CO||LA|lrl<br>CO||CO|I||||rV|8|
|||8||||Pl||CI<br>P\||h|h||ID|||||Ch<br>Ul|E|
||||||||||||||||||||off8|
||||||||||||||||||||rg0|
||||III|W||Irl<br>CO||LA<br>Cl<br>Cl|ID|LA<br>Pl|||P<br>CO|I||||LA|IO|
|Z||||||CO<br>CI||Ch|LA|CO<br> Ol|||crl<br>LA|||||hlA|5|
||||||||||||||||||||I-f|
||||||||||||||||||||II0|
||AI|||||||||||||||||||
|[8<br>~t CL<br>~X|tVO<br>tV<br>ClX|+ <br>IO0|IV<br> PV<br>0<br>IV|||CI<br>Ch|PI<br>CI|LA<br>pr<br>Ch|LA <br>Pl<br>O<br>'ID|PI<br>CO<br>CO<br>lrl<br>ID|||CI<br>rV<br>Ar||OOO<br>Pl<br>Af<br>fV||CO<br>LA<br>Pl||fO<br>CL<br>E<br>0C<br>Ol|
|e~<br>111<br>004<br>IL Z Z<br>g ZLL1<br>Z 4<br>~oz|OZ|'fO<br>N<br>N|N<br> fl|W||||ID<br>(4<br>'lD|||CO<br>ID||Ul<br>PI||||Af<br>LA|IA|C3l|
|Zz|DL||||||||||||||||||C|
|LU Cg<br>E~Z<br>I-<br>hg0|ZI-<br>OL'0|CN<br>g<br>Y '0||W||Ch<br>lrl<br>h|IV<br>CI|Ch<br>rh|LA<br>O<br>ID|IA<br>Af<br>CO<br> Pl|Ch<br>CO<br>LAO<br>LA||O<br>ID<br>'ID<br>t4(4||CO<br>ID<br>ID||LA<br>LA|I<br>Cfl<br>Ch|CI<br>Lf0<br>JQ<br>Cl|
|0|||||||||||||||||||Cf|
||||3<br>Z||||||||||||||||4J0|
||||||||||||||||||||X|
|||||||||||||LL1|||0Z|||fO|C|
|||||||||||||||C|||||e|
||||||CCN0<br>IO<br>IL0 0<br>4<br>LU<br>C<br>fO<br>08C||N<br>Ill<br>Cl|0<br>I|Ol<br>Z<br>g<br>0<br>X<br>ov-~<br>5u||I<br>I0|C<br>E<br>0 <br>Z|CI <br> g <br>~. <br>8|N<br> I<br>C<br> 10<br> I-|Z<br>I-Z<br>0X|Cl<br>zE<br>I<br>10||'CI <br>fO<br>fO<br>N <br>D<br>40 <br>I-|0<br>CI<br> .Iff0<br>FLE<br> S|





## 


## 



## 

||AS AT|31|st|DECEMBE|R 2022||
|---|---|---|---|---|---|---|
||||||2022|2021|
||||||6|6|
|Cash flows from operating|activities:||||||
|Net cash provided<br>by/(used|in) operating|||activities|(1,562)|378,437|
|Cash flows from investing|activities:||||||
|Dividends<br>and interest from investments|||||1,023|140|
|Purchase of property,<br>plant and equipment|||||(3,277)|(5,405)|
|Net cash provided<br>by/(used|in) investing||activities||(2,254)|(5,265)|
|Change<br>in cash and cash equivalents<br>reporting<br>period||in the|||(3,816)|373,172|
|Cash and cash equivalents<br>reporting<br>period|atthe beginning|||ofthe|852,692|479,520|
|Cash and cash equivalents<br>reporting<br>period|atthe end|of|the||848,876|852,692|
|Reconciliation of|net income/(expenditure)||||to net cash flow from operating||
|activities|||||||
||||||2022|2021|
||||||6|6|
|Net income/(expenditure)<br>for the reporting<br>period|||||221,308|142,671|
|Depreciation<br>charges|||||2,438|2,215|
|(Gains)/losses<br>on investments|||||||
|Dividends<br>and interest from|investments||||(1,023)|(140)|
|(Increase)/decrease<br>in debtors|||||(49,050)|86,553|
|Increase/(decrease)<br>in creditors|||||(175,235)|1'}7,138|
|/}/et cash provided by/Pnsedin)<br>operating||||activities|(1,562)|378,437|





## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

|2.<br>Voluntary<br>incom|e|||
|---|---|---|---|
|||2022|2021|
|The analysis ofvoluntary|income for the year is as follows:|E|E|
|Grants||942,202|839,103|
|||942,202|839,103|





## 

|linking<br>exposure||to ch|emi|cals to harmful<br>effects on health. The analysis ofexpen|cals to harmful<br>effects on health. The analysis ofexpen|cals to harmful<br>effects on health. The analysis ofexpen|cals to harmful<br>effects on health. The analysis ofexpen|diture|
|---|---|---|---|---|---|---|---|---|
|||||—————————-2022————————|||||
|||||Raising funds||Charitable|Total|Total|
|||||||activities|2022|2021|
|||||||E|E|E|
|Direct costs|||||||||
|Fundraising||||7,722|||7,722|14,976|
|Web management||and|IT|||11,381|11,381|9,558|
|support|||||||||
|Out-house<br>consultancy||||||148,774|148,774|285,496|
|Grants payable||||||52,149|52,149|26,053|
|eV - Administration||||||25,925|25,925||
|project costs||||||||2,375|
|Meetings<br>and events||||||16,485|16,485||
|Travel and expenses||||||12,550|12,550|1,369|
|Foreign currency||||||13,888|13,888|7,698|
|(gains)/losses|||||||||
|||||7 722||281 152|288,874|347 525|
|Supportcosts|||||||||
|Employment<br>costs||||59,313||330,455|389,768|301,580|
|Other staff costs||||||3,802|3,802||
|HR consultancy||||||||6,900|
|Insurance||||||3,811|3,811|2,997|
|Bookkeeping||||||3,247|3,247|8,309|
|Office expenses|8E|PPS||||22,777|22,777|25,624|
|PR Communication|||||||||
|Audit fee/IE fee||||||7,200|7,200|1,248|
|Bank charges||||||||175|
|Depreciation||||||2438|2438|2 214|
|||||59313||373730|433043|349047|
|||||67 035||654 882|721917|696572|
|Governance<br>costs included||||in Charitable|activities:||2022|2021|
||||||||E|E|
|Employment<br>costs|||||||||
|Bookkeeping fee|||||||7,001|2,742|
|Audit fee/Independent|||examination||||7 200|1 249|
||||||||14201|3991|





## 

## 

|||||||
|---|---|---|---|---|---|
|PRIOR YEAR|||----------|2021--------||
||||Raising funds|Charitable|Total|
|||||activities|2021|
|||||I|E|
|Direct costs||||||
|Fundraising|||14,976||14,976|
|Web management||and IT||9,558|9,558|
|support||||||
|Out-house<br>consultancy||||285,496|285,496|
|Grants payable||||26,053|26,053|
|Project costs||||2,375|2,375|
|Travel and expenses||||1,369|1,369|
|Foreign currency||||7,698|7,698|
|(gains)/losses||||||
||||14976|332549|347 525|
|Support costs||||||
|Employment<br>costs|||36,190|265,390|301,580|
|HR consultancy||||6,900|6,900|
|Insurance||||2,997|2,997|
|Bookkeeping||||8,309|8,309|
|Office expenses|8|PPS||25,624|25,624|
|PR Communication||||||
|Independent<br>examination||||1,248|1,248|
|Bank charges||||175|175|
|Depreciation||||2,214|2 214|
||||36 190|312857|349047|
||||51,166|645 406|696572|





## 

## 

|taff and Re|lated costs|||||
|---|---|---|---|---|---|
|||||2022<br>I|2021|
|Wages and|Salaries|||332,310|257,184|
|Social Security Costs||||32 323|22,808|
|Pension Costs||||25 134|21588|
|||||389,767|301,580|
|||||No|No|
|The average|number ofemployees|during|the year was:|8|8|



## 

## 



## 

## 

|||2022|
|---|---|---|
|||I|
|Cost|||
|At 1January|2022|15,459|
|Additions||3,277|
|Disposals|||
|At 31December 2022||18,736|
|Depreciation|||
|At 1January|2022|9,715|
|Charge for the year||2,438|
|Disposals|||
|At 31December 2022||12,153|
|Net book value at 31December 2022||6,583|
|Net book value at 31December 2021||5,744|



## 

||within|one year||||
|---|---|---|---|---|---|
|||||2022|2021|
|||||6|I|
||Accrued|income||45,180||
||Prepayments|||4 700|830|
|||||49,880|830|
|7.|Creditors:|Amounts|falling due|||
||within|one year||||
|||||2022|2021|
||||||I|
||Other Creditors|||30,208|35,597|
||Accruals|and deferred|income|18,145|181,214|
||Taxation|and Social Security|||6,777|
|||||48,353|223,588|





## 

## 

|8.<br>Un|res|tric|ted<br>funds|||||
|---|---|---|---|---|---|---|---|
|||||Balance|Transfers|Net Incoming|Balance|
|||||01/01/22<br>I||Resources<br>I|31/12/22<br>E|
|General funds||||526,252||221,660|747,912|
|Designated|funds||—Chemicals,|50,000|||50,000|
|Strategy<br>lk|Policy||Fund|||||
|||||576,252||221 660|797912|
|Comparative|||2021|||||
|||||Balance|Transfers|Net Incoming|Balance|
|||||01/01/21||Resources|31/12/21|
|||||f||E||
|General|funds|||366,765||159,487|526,252|
|Designated<br>Strategy 5||funds —Chemicals,<br> Policy Fund||50,000|||50,000|
|||||416765||159487|576,252|



## 

|9.<br>Rest|ricted|funds||||||
|---|---|---|---|---|---|---|---|
||||Balance|Income|Expenditure|Transfers|Balance|
||||01/01/22||||31/12/22|
||||E|E|||E|
|The Mava|Foundation||59,126|32,180|(91,306)|||
|Esmee Fairbairn||Foundation|300||(300)|||
|Other grants||||76,600|(10,294)||66,306|
|EURENI||||85,220|(96,165)||(10,945)|
|Tides Foundation||||22 276|18563||3713|
||||59426|216276|216628||59,074|
|Comparative||2021||||||
||||Balance|Income|Expenditure|Transfers|Balance|
||||01/01/21|E|I|6|31/12/21<br>I|
|GET - 2021||||40,000|(40,000)|||
|The Mava|Foundation||60,930|90,238|(92,042)||59,126|
|Esmee Fairbairn||Foundation|7,200||(6,900)||300|
|Adessium|Foundation||8,112||(8,112)|||
||||76 242|130238|147054||59426|





## 

## 

||||Restricted|Un-|Total|
|---|---|---|---|---|---|
|||||Restricted|2022|
||||E||I|
|Tangible|Fixed|Assets||6,583|6,583|
|Net Current Assets|||59074|791329|850 403|
||||59,074|797,912|856,986|
|Comparative||2021||||
||||Restricted|Un-|Total|
|||||Restricted|2021|
||||||I|
|Tangible|Fixed|Assets||5,744|5,744|
|Net Current Assets|||59426|570 508|629 934|
||||59,426|576,252|635,678|





## 

## 

## 

